Synthesis and Characterization
Scheme S1. The synthesis processes of GD1 -GD3. Reagent and conditions: (a) 2% Pa(OAc) 2 , 3% BINAP, 1.4eq Cs 2 CO 3 , 1.2eq benzophenone imine, toluene, 100 °C, 12h. (b) 0.5eq acetone, 1eq aqueous NaOH, ethanol, rt, 1h. (C) aqueous HCl (2.0 M), THF, rt.
Synthesis of compound 2, 5 and 8.
A three-neck round flask was charged with Pa(OAc)2 (0.2mmol), BINAP (0.3mmol), Cs2CO3 (24mmol) and 4-bromobenzaldehyde (1.85 g, 10mmol) and purged with argon three times, next added with toluene (20mL) containing benzophenone imine (22mmol). The mixture was stirred and heated to 100 °C for 12 hours. After cooled down to room temperature, the solvent was evaporated under reduced pressure and the residue was purified by flash column chromatography using hexane-ethyl acetate (10: 1, v/v) as an eluent to give a light yellow solid compound 2 (1.8g, 63% 
Synthesis of compound 3, 6 and 9.
Into a round-bottom flask charged with compound 2 (0.855g, 3mmol), was injected ethanol (20mL) and acetone (100μL, 1.5mmol). The reaction was stirred at room temperature for 1 hour, following ultrapure water (100mL) was added. Then the mixture was extracted with dichloromethane (50mL) three times and the organic layer was combined and dried. The solvent was evaporated under reduced pressure and the residue was purified by flash column chromatography using hexane-ethyl acetate (8:1, v/v) as an eluent to give a dark yellow solid compound 3 (0.7g, 80%). 
Synthesis of compound GD1, GD2 and GD3.
Into a round-bottom flask with compound 3 (0.592g, 1mmol) was injected THF (10 mL) and aqueous HCl (2.0 M, 1 mL). Then the mixture was partitioned between 0.5 M HCl and ethyl acetate. The aqueous layer was separated and made alkaline by adding saturated aqueous NaHCO3. The product was extracted with 50mL dichloromethane three times. The solvent was evaporated to yield orange solid GD1 (0.26g, 99%). Table S1 . Oligonucleotides used in this study purchased from Invitrogen. 
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